Brief: BioInvent, Transgene Report Positive Phase 1a Data On Oncolytic Virus Bt-001 In Solid Tumors

Transgene SA

25/05/2023 06:38

May 25 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT AND TRANSGENE REPORT POSITIVE PHASE 1A DATA ON
ONCOLYTIC VIRUS BT-001 IN SOLID TUMORS
    * INDEPENDENT SAFETY REVIEW COMMITTEE HAS NOW APPROVED
INITIATION
OF COMBINATION PART OF TRIAL WITH PEMBROLIZUMAB
    * FIRST PATIENT IN THIS COMBINATION COHORT IS EXPECTED TO BE
ENROLLED IN H2 2023

Source text for Eikon:  ID:nMFNMqG2V 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))